2025-01-22 - Analysis Report
## UnitedHealth Group Inc. (UNH) Stock Analysis Report

**1. Performance Comparison & Outperformance:**

UnitedHealth Group Inc. (UNH) is a diversified healthcare company offering a range of products and services.  Over the period analyzed, UNH significantly outperformed the S&P 500 (VOO).  The cumulative return for UNH is 142.15%, while the S&P 500's cumulative return is 120.36%.  This represents a difference of 21.8 percentage points. The relative outperformance, considering historical volatility, is at the 81.4th percentile (100 * (21.8 - (-4.2)) / (135.7 - (-4.2)) ).  This indicates UNH's strong performance relative to the broader market.  The provided alpha values consistently suggest above-market returns, though the recent negative CAGR indicates a period of underperformance.


**2. Recent Price Movement:**

* **Closing Price:** $524.99
* **5-day Moving Average:** $526.50
* **20-day Moving Average:** $515.05
* **60-day Moving Average:** $553.91

The price is currently below its 5-day and 60-day moving averages, suggesting a short-term downtrend and a potential longer-term bearish signal. The price is above its 20-day moving average, implying some short-term support. The recent price increase of $15.23 (from previous close) indicates a potential positive short-term momentum, despite being below the longer-term moving averages.

**3. Technical Indicators and Expected Return:**

* **RSI (Relative Strength Index):** 57.38  -  Indicates neither overbought nor oversold conditions; the market is relatively neutral.
* **PPO (Percentage Price Oscillator):** 0.59 - Suggests a bullish momentum, but it's important to consider it in the context of other indicators.
* **20-Day Relative Divergence:** -10.9% - Indicates a recent relative weakening of UNH compared to the S&P 500.  This short-term divergence could be a warning sign despite the positive price movement.
* **Expected Return:** 349.3% - This extraordinarily high projected return over the long term (2+ years) should be treated with caution.  Such projections are highly sensitive to assumptions and rarely accurate.

**4. Recent Earnings Analysis:**

The earnings data shows some volatility.  While Q3 2024 and Q4 2023 showed strong EPS, Q2 2024's negative EPS is concerning. Revenue consistently grew, but profit margins fluctuated.  Further investigation into the causes of the Q2 2024 EPS decline is needed. The duplication of the 2024-11-04 entry suggests an error in the data.

**5. Financial Information:**

Revenue has remained relatively stable and strong across the quarters, but profit margins have shown some decline from Q3 2023's high of 24.51%. Equity increased overall, but ROE is volatile, even showing a negative value in Q1 2024, suggesting potential challenges in profitability.  A deeper dive into the financial statements is needed for better understanding.

**7. Overall Analysis:**

UNH has historically outperformed the S&P 500, demonstrating strong long-term growth. However, recent data suggests potential short-term headwinds.  The price action shows a short-term increase, but is below important moving averages, indicating potential resistance.  While technical indicators are mixed, recent earnings show some volatility, and the Q2 2024 loss is particularly noteworthy. The exceptionally high projected long-term return should be treated with extreme skepticism.  Further due diligence, including a thorough review of financial statements and industry analysis, is crucial before making any investment decisions.

**8. Disclaimer:** This analysis is for informational purposes only and should not be considered financial advice.  Investing in the stock market involves risk, and past performance is not indicative of future results.  Consult with a qualified financial advisor before making any investment decisions.
